This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, C.-I.
Right arrow Articles by Choe, K.-W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, C.-I.
Right arrow Articles by Choe, K.-W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 760-766, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.760-766.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome

Cheol-In Kang,1 Sung-Han Kim,1 Wan Beom Park,1 Ki-Deok Lee,1 Hong-Bin Kim,1 Eui-Chong Kim,2,3 Myoung-don Oh,1,3* and Kang-Won Choe1,3

Departments of Internal Medicine,1 Laboratory Medicine, Seoul National University College of Medicine,2 Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea3

Received 23 May 2004/ Returned for modification 31 August 2004/ Accepted 11 October 2004

The marked increase in the incidence of infections due to antibiotic-resistant gram-negative bacilli in recent years is of great concern, as patients infected by those isolates might initially receive antibiotics that are inactive against the responsible pathogens. To evaluate the effect of inappropriate initial antimicrobial therapy on survival, a total of 286 patients with antibiotic-resistant gram-negative bacteremia, 61 patients with Escherichia coli bacteremia, 65 with Klebsiella pneumoniae bacteremia, 74 with Pseudomonas aeruginosa bacteremia, and 86 with Enterobacter bacteremia, were analyzed retrospectively. If a patient received at least one antimicrobial agent to which the causative microorganisms were susceptible within 24 h of blood culture collection, the initial antimicrobial therapy was considered to have been appropriate. High-risk sources of bacteremia were defined as the lung, peritoneum, or an unknown source. The main outcome measure was 30-day mortality. Of the 286 patients, 135 (47.2%) received appropriate initial empirical antimicrobial therapy, and the remaining 151 (52.8%) patients received inappropriate therapy. The adequately treated group had a 27.4% mortality rate, whereas the inadequately treated group had a 38.4% mortality rate (P = 0.049). Multivariate analysis showed that the significant independent risk factors of mortality were presentation with septic shock, a high-risk source of bacteremia, P. aeruginosa infection, and an increasing APACHE II score. In the subgroup of patients (n = 132) with a high-risk source of bacteremia, inappropriate initial antimicrobial therapy was independently associated with increased mortality (odds ratio, 3.64; 95% confidence interval, 1.13 to 11.72; P = 0.030). Our data suggest that inappropriate initial antimicrobial therapy is associated with adverse outcome in antibiotic-resistant gram-negative bacteremia, particularly in patients with a high-risk source of bacteremia.

* Corresponding author. Mailing address: Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong Chongno-gu, Seoul 110-744, Republic of Korea. Phone: 82-2-072-2945. Fax: 82-2-762-9662. E-mail: mdohmd{at}snu.ac.kr.

Antimicrobial Agents and Chemotherapy, February 2005, p. 760-766, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.760-766.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Scheetz, M. H., Bolon, M. K., Postelnick, M., Noskin, G. A., Lee, T. A. (2009). Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother 63: 816-825 [Abstract] [Full Text]  
  • Al-Hasan, M. N., Wilson, J. W., Lahr, B. D., Thomsen, K. M., Eckel-Passow, J. E., Vetter, E. A., Tleyjeh, I. M., Baddour, L. M. (2009). {beta}-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli. Antimicrob. Agents Chemother. 53: 1386-1394 [Abstract] [Full Text]  
  • Ortega, M., Marco, F., Soriano, A., Almela, M., Martinez, J. A., Munoz, A., Mensa, J. (2009). Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 63: 568-574 [Abstract] [Full Text]  
  • Marschall, J., Tibbetts, R. J., Dunne, W. M. Jr., Frye, J. G., Fraser, V. J., Warren, D. K. (2009). Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility. J. Clin. Microbiol. 47: 239-241 [Abstract] [Full Text]  
  • MacGowan, A. P., on behalf of the BSAC Working Parties on Resistanc, (2008). Clinical implications of antimicrobial resistance for therapy. J Antimicrob Chemother 62: ii105-ii114 [Abstract] [Full Text]  
  • Marschall, J., Agniel, D., Fraser, V. J., Doherty, J., Warren, D. K. (2008). Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. J Antimicrob Chemother 61: 1376-1383 [Abstract] [Full Text]  
  • Marchaim, D., Navon-Venezia, S., Schwaber, M. J., Carmeli, Y. (2008). Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes. Antimicrob. Agents Chemother. 52: 1413-1418 [Abstract] [Full Text]  
  • Riedel, S., Bourbeau, P., Swartz, B., Brecher, S., Carroll, K. C., Stamper, P. D., Dunne, W. M., McCardle, T., Walk, N., Fiebelkorn, K., Sewell, D., Richter, S. S., Beekmann, S., Doern, G. V. (2008). Timing of Specimen Collection for Blood Cultures from Febrile Patients with Bacteremia. J. Clin. Microbiol. 46: 1381-1385 [Abstract] [Full Text]  
  • Wheeler, A. P. (2007). Recent Developments in the Diagnosis and Management of Severe Sepsis. Chest 132: 1967-1976 [Abstract] [Full Text]  
  • Cheong, H. S., Kang, C.-I., Kwon, K. T., Heo, S. T., Wi, Y. M., Kim, E. S., Lee, J. S., Ko, K. S., Chung, D. R., Lee, N. Y., Song, J.-H., Peck, K. R. (2007). Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia. J Antimicrob Chemother 60: 1355-1360 [Abstract] [Full Text]  
  • Peralta, G., Sanchez, M. B., Garrido, J. C., De Benito, I., Cano, M. E., Martinez-Martinez, L., Roiz, M. P. (2007). Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 60: 855-863 [Abstract] [Full Text]  
  • Lodise, T. P. Jr., Patel, N., Kwa, A., Graves, J., Furuno, J. P., Graffunder, E., Lomaestro, B., McGregor, J. C. (2007). Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection. Antimicrob. Agents Chemother. 51: 3510-3515 [Abstract] [Full Text]  
  • Osih, R. B., McGregor, J. C., Rich, S. E., Moore, A. C., Furuno, J. P., Perencevich, E. N., Harris, A. D. (2007). Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia. Antimicrob. Agents Chemother. 51: 839-844 [Abstract] [Full Text]  
  • Wellinghausen, N., Pietzcker, T., Poppert, S., Belak, S., Fieser, N., Bartel, M., Essig, A. (2007). Evaluation of the Merlin MICRONAUT System for Rapid Direct Susceptibility Testing of Gram-Positive Cocci and Gram-Negative Bacilli from Positive Blood Cultures. J. Clin. Microbiol. 45: 789-795 [Abstract] [Full Text]  
  • Paul, M., Andreassen, S., Tacconelli, E., Nielsen, A. D., Almanasreh, N., Frank, U., Cauda, R., Leibovici, L., on behalf of the TREAT Study Group, (2006). Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother 58: 1238-1245 [Abstract] [Full Text]  
  • Scarsi, K. K., Feinglass, J. M., Scheetz, M. H., Postelnick, M. J., Bolon, M. K., Noskin, G. A. (2006). Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.. Antimicrob. Agents Chemother. 50: 3355-3360 [Abstract] [Full Text]  
  • Metan, G., Uzun, O. (2005). Impact of Initial Antimicrobial Therapy in Patients with Bloodstream Infections Caused by Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 49: 3980-3981 [Full Text]  
  • Drago, L., De Vecchi, E., Nicola, L., Tocalli, L., Gismondo, M. R. (2005). In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with {beta}-lactams and amikacin. J Antimicrob Chemother 56: 353-359 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»